PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells.

Saved in:
Bibliographic Details
Title: PLZF targets developmental enhancers for activation during osteogenic differentiation of human mesenchymal stem cells.
Authors: Agrawal Singh S; Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Hematology, Cambridge Institute for Medical Research and Welcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom.; Centre for Epigenetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Lerdrup M; Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Centre for Epigenetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Gomes AR; Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Centre for Epigenetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., van de Werken HJ; Department of Cell Biology, University Medical Center, Rotterdam, Netherlands.; Cancer Computational Biology Center, University Medical Center, Rotterdam, Netherlands.; Department of Urology, University Medical Center, Rotterdam, Netherlands., Vilstrup Johansen J; Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Centre for Epigenetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Biology, The Bioinformatics Centre, University of Copenhagen, Copenhagen, Denmark., Andersson R; Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Centre for Epigenetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Biology, The Bioinformatics Centre, University of Copenhagen, Copenhagen, Denmark., Sandelin A; Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Centre for Epigenetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Department of Biology, The Bioinformatics Centre, University of Copenhagen, Copenhagen, Denmark., Helin K; The Novo Nordisk Center for Stem Cell Biology, Faculty of Health and Medical Sciences University of Copenhagen, Copenhagen, Denmark.; Cell Biology Program, Memorial Sloan Kettering Cancer Center, New York, United States.; Center for Epigenetics Research, Memorial Sloan Kettering Cancer Center, New York, United States., Hansen K; Biotech Research and Innovation Centre (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.; Centre for Epigenetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Source: ELife [Elife] 2019 Jan 23; Vol. 8. Date of Electronic Publication: 2019 Jan 23.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: eLife Sciences Publications, Ltd Country of Publication: England NLM ID: 101579614 Publication Model: Electronic Cited Medium: Internet ISSN: 2050-084X (Electronic) Linking ISSN: 2050084X NLM ISO Abbreviation: Elife Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2050-084X
DOI:10.7554/eLife.40364